Prchal, Josef T.
Josef Prchal americký lékař-hematolog českého původu
Prchal, Josef T., 19..-....
VIAF ID: 160949845 (Personal)
Permalink: http://viaf.org/viaf/160949845
Preferred Forms
- 100 0 _ ‡a Josef Prchal ‡c americký lékař-hematolog českého původu
-
- 100 1 _ ‡a Prchal, Josef T.
-
- 100 1 _ ‡a Prchal, Josef T.
-
-
-
- 100 1 _ ‡a Prchal, Josef T.
- 100 1 _ ‡a Prchal, Josef T., ‡d 19..-....
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
Allogeneic haematopoietic cell transplantation for myelofibrosis in 30 patients 60-78 years of age. | |
Experimental Modeling of Myeloproliferative Neoplasms | |
Hypoxia and thrombosis | |
Imatinib effect on growth and signal transduction in polycythemia vera | |
Imatinib mesylate therapy for polycythemia vera: final result of a phase II study initiated in 2001 | |
In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs | |
Interim analysis of safety and efficacy of ruxolitinib in patients with myelofibrosis and low platelet counts | |
Ironing out the role of hepcidin in infection. | |
The JAK kinase inhibitor CP-690,550 suppresses the growth of human polycythemia vera cells carrying the JAK2V617F mutation | |
JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia | |
Large-Scale Identification of Clonal Hematopoiesis and Mutations Recurrent in Blood Cancers | |
Metabolic insight into mechanisms of high-altitude adaptation in Tibetans | |
Novel insights into the polycythemia-paraganglioma-somatostatinoma syndrome | |
Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea | |
Red cell and its diseases | |
Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia | |
Williams hematology |